TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/21/05 19:13 | 10/20/05 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Richmond Mark Sir | CA | D | S.d | -1,702 | 85.09 | 0 | -20 | -100 | 0 | D | |||||||||||||||
7/15/05 17:03 | 7/13/05 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Richmond Mark Sir | CA | D | S.d | -1,743 | 87.15 | 0 | -20 | -100 | 0 | D | |||||||||||||||
2/23/05 18:22 | 2/22/05 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Richmond Mark Sir | CA | D | S.d | -932 | 46.62 | 0 | -20 | -100 | 0 | D | |||||||||||||||
11/8/04 18:26 | 11/4/04 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Richmond Mark Sir | CA | D | S.d | -389 | 48.63 | 0 | -8 | -100 | 0 | D | |||||||||||||||
4/14/04 18:45 | 4/12/04 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Richmond Mark Sir | CA | D | S.d | -835 | 111.34 | 0 | -8 | -100 | 0 | D | |||||||||||||||
3/2/04 19:22 | 2/27/04 | DNA | Genentech Inc | DE | Health | Drug | Pharmaceutical Preparations | Richmond Mark Sir | CA | D | S.d | -815 | 108.70 | 0 | -8 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |